globalchange  > 气候变化与战略
DOI: 10.1016/j.scib.2021.01.023
论文题名:
Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects
作者: Feng L.; Lu S.; Zheng Z.; Chen Y.; Zhao Y.; Song K.; Xue H.; Jin L.; Li Y.; Huang C.; Li Y.-M.; Zhang J.
刊名: Science Bulletin
ISSN: 20959273
出版年: 2021
卷: 66, 期:15
起始页码: 1559
结束页码: 1570
语种: 英语
中文关键词: Additive activation ; Allosteric hotspot ; Cobinding ; Combination therapy ; PPARγ ; Side effects
英文关键词: Additives ; Cytology ; Drug interactions ; Mammals ; Additive activation ; Allosteric hotspot ; Cobinding ; Combination therapy ; Hot spot ; Peroxisome proliferator activated receptor-γ ; Peroxisome proliferator-activated receptor ; Rosiglitazone ; Side effect ; Thiazolidinediones ; Chemical activation
英文摘要: Thiazolidinediones (TZDs), such as rosiglitazone (RSG), which activates peroxisome proliferator activated receptor-γ (PPARγ), are a potent class of oral antidiabetic agents with good durability. However, the clinical use of TZDs is challenging because of their side effects, including weight gain and hepatotoxicity. Here, we found that bavachinin (BVC), a lead natural product, additively activates PPARγ with low-dose RSG to preserve the maximum antidiabetic effects while reducing weight gain and hepatotoxicity in db/db mice caused by RSG monotherapy. Structural and biochemical assays demonstrated that an unexplored hotspot around Met329 and Ser332 in helix 5 is triggered by BVC cobinding to RSG-bound PPARγ, thereby allosterically stabilizing the active state of the activation-function 2 motif responsible for additive activation with RSG. Based on this hotspot, we discovered a series of new classes of allosteric agonists inducing the activity of TZDs in the same manner as BVC. Together, our data illustrate that the hotspot of PPARγ is druggable for the discovery of new allosteric synergists, and the combination therapy of allosteric synergists and TZD drugs may provide a potential alternative approach to the treatment of type 2 diabetes mellitus. © 2021 Science China Press
Citation statistics:
资源类型: 期刊论文
标识符: http://119.78.100.158/handle/2HF3EXSE/170243
Appears in Collections:气候变化与战略

Files in This Item:

There are no files associated with this item.


作者单位: Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China; Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute, Chinese Academy of Science, Shanghai, 201210, China; State Key Laboratory of Cellular Stress Biology, Innovation Centre for Cell Signaling Network, School of Life Sciences, Xiamen University, Fujian, 361005, China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China

Recommended Citation:
Feng L.,Lu S.,Zheng Z.,et al. Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects[J]. Science Bulletin,2021-01-01,66(15)
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Feng L.]'s Articles
[Lu S.]'s Articles
[Zheng Z.]'s Articles
百度学术
Similar articles in Baidu Scholar
[Feng L.]'s Articles
[Lu S.]'s Articles
[Zheng Z.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Feng L.]‘s Articles
[Lu S.]‘s Articles
[Zheng Z.]‘s Articles
Related Copyright Policies
Null
收藏/分享
所有评论 (0)
暂无评论
 

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.